Physician profile
James A Clark
NPI 1861798316
$2,051.61
in general payments reported to CMS, 2019-2025
11 companies · $628 in 2025
The $628 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.32 · 2022: $284 · 2023: $537 · 2024: $570 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $900.41 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $331.19 | 2022-2025 | Dupixent |
| Inspire Medical Systems, INC. | $316.56 | 2022-2025 | Inspire |
| Optinose US, INC. | $167.75 | 2022-2025 | |
| Glaxosmithkline, LLC. | $116.32 | 2024 | Nucala |
| Olympus America INC. | $65.51 | 2021-2024 | Rhino-Laryngo Videoscope, Olympus |
| Smith+Nephew, INC. | $58.54 | 2025 | Tula |
| Hikma Pharmaceuticals USA | $32.86 | 2024 | Ryaltris |
| Medtronic, INC. | $24.20 | 2024 | Propel |
| Acclarent, INC | $20.12 | 2023 | Relieva Spinplus |
| Alk-Abello, INC | $18.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.